Cytokeratin 4 Activators
Cytokeratin 4 activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of Cytokeratin 4 through modulation of various signaling pathways and cellular processes. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8) activate protein kinase C (PKC), which in turn phosphorylates Cytokeratin 4, potentially impacting its structural and functional role within the cytoskeleton. Similarly, Forskolin and 8-Br-cAMP elevate intracellular cAMP levels, leading to protein kinase A (PKA) activation that may phosphorylate Cytokeratin 4, suggesting an enhancive effect on its cytoskeletal stability and interactions. Epidermal Growth Factor (EGF) and Insulin, through the activation of their respective receptor pathways, culminate in the activation of kinases that can modify cytoskeletal proteins, thereby influencing the function of Cytokeratin 4 in maintaining cellular architecture.
Cytokeratin 4 Activators are a diverse array of chemical compounds that indirectly support the structural and functional enhancement of Cytokeratin 4, a key intermediate filament protein in epithelial cells. Retinoic acid and Vitamin D3, by promoting cellular differentiation, contribute to the increased expression and incorporation of Cytokeratin 4 into the cytoskeleton, thereby enhancing its structural role in cell integrity. Similarly, EGF stimulates keratinocyte proliferation and differentiation, indirectly leading to a higher functional presence of Cytokeratin 4. Acitretin and Zinc sulfate also play a crucial role in keratinization and differentiation, further supporting the presence and stability of Cytokeratin 4 in epithelial tissues. Lithium carbonate and Nicotinamide, by modulating cellular differentiation signaling, contribute to the regulation and proper functioning of Cytokeratin 4.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a protein kinase C (PKC) activator. PKC is known to phosphorylate intermediate filament proteins, which can result in reorganization of the cytoskeleton. Enhanced PKC activity could potentially lead to changes in Cytokeratin 4 structure and function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). By inhibiting these phosphatases, it maintains phosphorylation states of proteins longer, which could affect the phosphorylation state of Cytokeratin 4, thus affecting its function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a specific inhibitor of PP1 and PP2A like Calyculin A. Inhibiting these phosphatases can lead to the hyperphosphorylation of cytoskeletal proteins, potentially enhancing the functional activity of Cytokeratin 4 by altering its dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which indirectly activates PKA. PKA can phosphorylate various proteins and could potentially influence the phosphorylation status of Cytokeratin 4, possibly enhancing its structural stability or interactions. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate multiple signaling pathways including the MAPK and PI3K pathways. Activation of these pathways can lead to alterations in cytoskeletal dynamics, which may enhance the functional activity of Cytokeratin 4. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can result in phosphorylation of cytoskeletal proteins and may positively influence the function of Cytokeratin 4. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid can modulate gene expression and has been shown to influence the expression of cytoskeletal proteins. It could potentially enhance the functional activity of Cytokeratin 4 by modulating its expression or post-translational modification. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, which could lead to altered phosphorylation states of various proteins. This inhibition may indirectly affect the phosphorylation status and function of Cytokeratin 4. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, but at low doses, it can act selectively. Selective inhibition of kinases could relieve negative regulation on Cytokeratin 4, potentially enhancing its activity. | ||||||